PL2520295T3 - Sposób zapobiegania i leczenia zapalenia błon śluzowych - Google Patents

Sposób zapobiegania i leczenia zapalenia błon śluzowych

Info

Publication number
PL2520295T3
PL2520295T3 PL12177486T PL12177486T PL2520295T3 PL 2520295 T3 PL2520295 T3 PL 2520295T3 PL 12177486 T PL12177486 T PL 12177486T PL 12177486 T PL12177486 T PL 12177486T PL 2520295 T3 PL2520295 T3 PL 2520295T3
Authority
PL
Poland
Prior art keywords
preventing
methods
treating mucositis
mucositis
treating
Prior art date
Application number
PL12177486T
Other languages
English (en)
Inventor
Ezio Bombardelli
Paolo Morazzoni
Original Assignee
Indena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37309334&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2520295(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indena S.P.A. filed Critical Indena S.P.A.
Publication of PL2520295T3 publication Critical patent/PL2520295T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/51—Gentianaceae (Gentian family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
PL12177486T 2006-07-28 2007-07-27 Sposób zapobiegania i leczenia zapalenia błon śluzowych PL2520295T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06015732A EP1882473A1 (en) 2006-07-28 2006-07-28 Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs

Publications (1)

Publication Number Publication Date
PL2520295T3 true PL2520295T3 (pl) 2017-02-28

Family

ID=37309334

Family Applications (2)

Application Number Title Priority Date Filing Date
PL12177486T PL2520295T3 (pl) 2006-07-28 2007-07-27 Sposób zapobiegania i leczenia zapalenia błon śluzowych
PL07804655T PL2046324T3 (pl) 2006-07-28 2007-07-27 Leczenie i zapobieganie zapaleniu błon śluzowych pochodnymi antocyjanidyny

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL07804655T PL2046324T3 (pl) 2006-07-28 2007-07-27 Leczenie i zapobieganie zapaleniu błon śluzowych pochodnymi antocyjanidyny

Country Status (20)

Country Link
US (3) US20080026058A1 (pl)
EP (4) EP1882473A1 (pl)
JP (1) JP5433415B2 (pl)
KR (1) KR20090052852A (pl)
CN (1) CN101495114A (pl)
AU (1) AU2007278959B2 (pl)
BR (1) BRPI0715364A2 (pl)
CA (2) CA2659211C (pl)
DK (2) DK2046324T3 (pl)
ES (2) ES2629306T3 (pl)
HU (2) HUE031941T2 (pl)
IL (1) IL196737A (pl)
MX (1) MX2009001064A (pl)
NO (1) NO341742B1 (pl)
PL (2) PL2520295T3 (pl)
PT (2) PT2046324T (pl)
RU (1) RU2438693C2 (pl)
SG (1) SG172745A1 (pl)
SI (2) SI2046324T1 (pl)
WO (1) WO2008012666A2 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20042414A1 (it) * 2004-12-17 2005-03-17 Indena Spa Formulazione per il trattamento di affezioni delle prime vie respiratorie
ITMI20080038A1 (it) * 2008-01-11 2009-07-12 Indena Spa Formulazioni per il trattamento di mucositi indotte da terapia antitumorale o immunosoppressiva
ITMI20080395A1 (it) * 2008-03-10 2009-09-11 Indena Spa Formulazioni per il trattamento delle verruche e delle placche psoriatiche
CN102014906A (zh) * 2008-04-24 2011-04-13 因德纳有限公司 治疗具有慢性炎症的阴道感染的组合物
AU2009240294B2 (en) * 2008-04-24 2014-04-10 Indena S.P.A. Compositions for the treatment and prevention of infections of the oral cavity
DK2133079T3 (da) * 2008-06-12 2011-12-12 Indena Spa Sammensætninger til behandling af vaginale infektioner med kronisk inflammation
ES2334746B1 (es) * 2008-07-23 2011-01-28 Feedback Trayer, S.L. Producto para la higiene intima a base de mirtillo rojo y procedimiento para su preparacion.
JP2010215532A (ja) * 2009-03-13 2010-09-30 Ands Corporation コラーゲンゲル収縮促進剤
WO2011048479A2 (en) * 2009-10-21 2011-04-28 Maqui New Life S.A. Compositions that include anthocyanidins and methods of use
IT1402749B1 (it) * 2010-10-28 2013-09-18 Indena Spa Composizioni per il trattamento di ulcere periferiche di varia origine
FR2979241B1 (fr) 2011-08-30 2014-05-09 Nutrialys Medical Nutrition Sa Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux
ITMI20111671A1 (it) * 2011-09-16 2013-03-17 Indena Spa Composizioni per il trattamento di ulcere periferiche di varia origine
CN104145966B (zh) * 2014-07-23 2016-09-07 中国人民解放军第二军医大学 白屈菜红碱在制备抗真菌生物被膜药物中的应用
JP6700083B2 (ja) * 2016-03-30 2020-05-27 株式会社ファンケル 口腔内速崩壊錠
JP6700084B2 (ja) * 2016-03-30 2020-05-27 株式会社ファンケル コーティング顆粒
CN106361755A (zh) * 2016-10-23 2017-02-01 徐州诺克非医药科技有限公司 含Zoarenone用于治疗溃疡性结肠炎的药物
KR20190079641A (ko) * 2016-10-27 2019-07-05 엔에스이 프로덕츠, 인크. 장 건강 촉진 조성물
CN108721276B (zh) * 2018-06-29 2020-01-07 佛山科学技术学院 一种小白菊内酯和原花青素复方药物组合物及其用途
CN109549946B (zh) * 2019-01-08 2020-12-18 牡丹江医学院 一种治疗咽炎的药物及其制备方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145412A (en) * 1977-02-14 1979-03-20 Vipont Chemical Company Composition for application to oral cavity and method for preparation thereof
GB2062991B (en) * 1979-11-07 1983-11-16 Image Data Products Ltd Position co-ordinates digitiser
US4818533A (en) * 1985-07-09 1989-04-04 Vipont Pharmaceutical, Inc. Production of high purity alkaloids
IT1231725B (it) * 1989-08-11 1991-12-21 Inverni Della Beffa Spa Procedimento per la preparazione di estratti ad alto contenuto in antocianosidi.
DE69020341T2 (de) 1990-07-05 1995-11-02 Indena Spa Echinacea-Extrakte, Verfahren zur Herstellung und Zubereitungen, die sie enthalten.
JP2754906B2 (ja) * 1990-11-06 1998-05-20 日本電気株式会社 半導体集積回路
US5073368A (en) * 1991-05-15 1991-12-17 Colgate-Palmolive Company Sanguinaria mouthrinse having improved anti microbial activity and stability
US5378465A (en) 1993-05-24 1995-01-03 Zeines; Victor Solution for application to an oral cavity
IT1270999B (it) * 1994-07-26 1997-05-26 Indena Spa Formulazioni a base di cumarine e loro uso in campo farmaceutico e cosmetico
NO943860D0 (no) * 1994-10-13 1994-10-13 Unifob En kjemisk forbindelse og et preparat til bruk som terapeutikum
WO1997041137A1 (en) * 1996-04-17 1997-11-06 Unifob Use of anthocyanidin and anthocyanidin derivatives
US5840322A (en) * 1996-12-19 1998-11-24 Ramot-University Authority For Applied Research & Industrial Devel. Ltd. Anti-oral-microbial adhesion fraction derived from vaccinium
ITMI981542A1 (it) 1998-07-07 2000-01-07 Indena Spa Estratti di zanthoxylum bungeanum e loro formulazioni farmaceutiche e cosmetiche
US6162393A (en) * 1998-08-06 2000-12-19 Ndt, Inc. Contact lens and ophthalmic solutions
JP2001039844A (ja) * 1999-07-29 2001-02-13 Kikkoman Corp 咽喉用うがい剤
KR100776465B1 (ko) * 1999-08-27 2007-11-16 미시간 스테이트 유니버시티 천연 사이클로옥시게나제 저해물질을 함유한 식이요법용보조식품
ITMI20000628A1 (it) * 2000-03-24 2001-09-24 Indena Spa Composizioni cosmetiche ritardanti la ricrescita dei peli
AT500455B1 (de) * 2000-09-15 2007-08-15 Roth Hermann Dr Verwendung von benzophenanthridinalkaloiden als futteradditiv
EP1236466B1 (en) * 2001-02-28 2011-09-21 Axiomedic Ltd. Solid self-adhesive compositions for topical treatment of oral mucosal disorders
AU2002311922A1 (en) * 2001-05-15 2002-11-25 The Procter And Gamble Company Oral care compositions
IL143318A0 (en) * 2001-05-23 2002-04-21 Herbal Synthesis Corp Herbal compositions for the treatment of mucosal lesions
US6596313B2 (en) * 2001-08-06 2003-07-22 The Quigley Corporation Nutritional supplement and methods of using it
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
WO2003088986A1 (en) * 2002-04-16 2003-10-30 Isis Innovation Limited Curcumin for the prevention and/or treatment of tissue damage
US7790762B2 (en) * 2002-10-31 2010-09-07 National Jewish Health Compounds and methods for thiol-containing compound efflux and cancer treatment
GB0230042D0 (en) * 2002-12-23 2003-01-29 Britannia Pharmaceuticals Ltd Composition comprising plant extract and a sugar for use in inhibiting bacterial proliferation
FR2856304B1 (fr) * 2003-06-20 2006-03-03 Natural Product Consulting Composition pour la prevention des infections du systeme urinaire
ITMI20032287A1 (it) * 2003-11-24 2005-05-25 Indena Spa Composizioni per il trattamento delle affezioni del cavo orale e delle prime vie respiratorie
KR101531116B1 (ko) * 2004-04-28 2015-06-23 누트리션 사이언스 파트너스 리미티드 천심련으로부터의 조추출물
WO2006024545A1 (en) * 2004-09-03 2006-03-09 Stichting Voor De Technische Wetenschappen Fused bicyclic natural compounds and their use as inhibitors of parp and parp-mediated inflammatory processes
ITMI20042414A1 (it) * 2004-12-17 2005-03-17 Indena Spa Formulazione per il trattamento di affezioni delle prime vie respiratorie
US20060135610A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Cardiovascular compositions
CA2622286A1 (en) * 2005-09-27 2007-04-05 University Of Kentucky Research Foundation Anti-inflammatory composition comprising berry extract

Also Published As

Publication number Publication date
DK2046324T3 (en) 2017-06-12
US9730952B2 (en) 2017-08-15
HUE031034T2 (en) 2017-06-28
RU2438693C2 (ru) 2012-01-10
EP2520295B1 (en) 2016-08-17
US20080026058A1 (en) 2008-01-31
CN101495114A (zh) 2009-07-29
JP5433415B2 (ja) 2014-03-05
SI2520295T1 (sl) 2016-11-30
AU2007278959B2 (en) 2013-03-28
RU2009102649A (ru) 2010-08-10
WO2008012666A3 (en) 2008-09-04
ES2629306T3 (es) 2017-08-08
EP2046324B1 (en) 2017-04-05
US20170304341A1 (en) 2017-10-26
EP1882473A1 (en) 2008-01-30
SG172745A1 (en) 2011-07-28
NO20090887L (no) 2009-02-26
AU2007278959A1 (en) 2008-01-31
JP2009544687A (ja) 2009-12-17
ES2602786T3 (es) 2017-02-22
DK2520295T3 (en) 2016-12-12
PT2046324T (pt) 2017-07-03
BRPI0715364A2 (pt) 2013-06-18
WO2008012666A2 (en) 2008-01-31
US20100310684A1 (en) 2010-12-09
PL2046324T3 (pl) 2017-09-29
IL196737A (en) 2014-05-28
IL196737A0 (en) 2009-11-18
PT2520295T (pt) 2016-11-21
EP2522345A1 (en) 2012-11-14
NO341742B1 (no) 2018-01-15
CA2935902A1 (en) 2008-01-31
EP2520295A1 (en) 2012-11-07
HUE031941T2 (en) 2017-08-28
MX2009001064A (es) 2009-02-05
KR20090052852A (ko) 2009-05-26
CA2659211A1 (en) 2008-01-31
EP2046324A2 (en) 2009-04-15
CA2659211C (en) 2016-08-16
CA2935902C (en) 2019-02-19
SI2046324T1 (sl) 2017-06-30

Similar Documents

Publication Publication Date Title
PL2520295T3 (pl) Sposób zapobiegania i leczenia zapalenia błon śluzowych
EP2088952A4 (en) METHODS AND DEVICES FOR PROCESSING FABRICS
HK1125868A1 (en) Compositions and methods for treating bone
GB0704718D0 (en) Compounds and methods for preventing and treating mucositis
GB201109769D0 (en) System and method
GB0613500D0 (en) Apparatus and Methods
IL197781A0 (en) Lyophilization methods and apparatuses
IL209895A (en) Compounds for the prevention and / or treatment of β-amyloidoses
IL247957A0 (en) Anti-ephrinb2 antibodies and methods of using them
ZA200900140B (en) Methods and compositions for treating biofilms
GB2442535B (en) Method and articles
SI1867398T1 (sl) Naprave in postopki za dekoriranje podolgovatih elementov
EP1951908A4 (en) METHODS RELATED TO DIAGNOSIS AND TREATMENT OF DEPRESSIONS
EP1987184A4 (en) CARBON / CARBON PARTS AND METHODS OF MAKING SAME
EP2037941A4 (en) COBALAMINE COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF MUCOSITIS
HK1117993A1 (en) Method for treating and preventing scuticociliatosis in fishes
EP2008610A4 (en) TREATMENT DEVICE AND PROCESSING METHOD
GB0603975D0 (en) Methods and agents for reducing oxidative stress
GB0718918D0 (en) Compositions and methods for treating skin conditions
HK1129596A1 (en) Methods and compositions for treating disease
EP2132251A4 (en) COMPOSITION AND METHOD
GB0620930D0 (en) Composition and method for use thereof
GB0625208D0 (en) Composition and method
IL197703A0 (en) Subunguicide, and method for treating onychomycosis
ZA201004212B (en) Method and composition for treating an alpha adrenoceptor-mediated condition